Subscribe to our Newsletters !!
Eliminating sticker residue is a small yet frustra
Recent advances in precision science have abandone
The Nobel Prize in Physiology or Medicine awarded
Giesen, Germany. 26 January 2026 - At Interpack 20
Alembic Pharmaceuticals Limited (Alembic) today an
Tofu has been a favorite food for vegetarians and
Dear Readers, Welcome to the latest issue of Micro
BioNTech and Shanghai Fosun Pharmaceutical said on Wednesday they would launch a Phase II clinical trial of BioNTech’s experimental COVID-19 vaccine in China.
The vaccine, known as BNT162b2, will be tested on volunteers at the Jiangsu Provincial Center for Disease Control and Prevention to assess safety and immunogenicity, eyeing future acceptance in China, both firms said in a statement.
BioNTech is also working with U.S. pharma giant Pfizer on the vaccine and the spouses said last week they were expecting to win approval in the United States and Europe this season after trial results revealed the compound had a 95% efficacy rate and caused no serious side effects.
